Possible Advantages Deriving from Patiromer Use in Hypertensive Patients Made Hyperkalemic by Renin–Angiotensin–Aldosterone Blocking Agents
Crossref DOI link: https://doi.org/10.1007/s40292-021-00478-2
Published Online: 2021-10-28
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borghi, Claudio
Ferri, Claudio
Pontremoli, Roberto
Sechi, Leonardo
Grassi, Guido
Text and Data Mining valid from 2021-10-28
Version of Record valid from 2021-10-28
Article History
Received: 25 September 2021
Accepted: 8 October 2021
First Online: 28 October 2021
Declarations
:
: There are no conflicts of interest.